These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 46905)

  • 21. Apparently healthy HBs antigen carriers: ABO blood group distribution and ay : ad ratio.
    Babes VT; Stătescu F; Milu A; Steiner N
    Virologie; 1976; 27(3):157-9. PubMed ID: 1006973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of hepatitis B "e" antigen and its antibody in various HBsAg carrier populations.
    Szmuness W; Neurath AR; Stevens CE; Strick N; Harley EJ
    Am J Epidemiol; 1981 Feb; 113(2):113-21. PubMed ID: 7468569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FURTHER OBSERVATIONS ON THE BLOOD GROUP ANTIGEN BU-A.
    LEWIS M; CHOWN B; KAITA H; PHILIPPS S
    Am J Hum Genet; 1964 Jun; 16(2):256-60. PubMed ID: 14174806
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevalence of hepatitis B surface antigen & its subtypes in high risk group subjects & voluntary blood donors in Bombay.
    Elavia AJ; Banker DD
    Indian J Med Res; 1991 Sep; 93():280-5. PubMed ID: 1778613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to delta antigen in asymptomatic hepatitis B surface antigen-reactive blood donors in the United States and their association with other markers of hepatitis B virus.
    Nath N; Mushahwar IK; Fang CT; Berberian H; Dodd RY
    Am J Epidemiol; 1985 Aug; 122(2):218-25. PubMed ID: 4014206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus DNA and e antigen in serum from blood donors in the United Kingdom positive for hepatitis B surface antigen.
    Harrison TJ; Bal V; Wheeler EG; Meacock TJ; Harrison JF; Zuckerman AJ
    Br Med J (Clin Res Ed); 1985 Mar; 290(6469):663-4. PubMed ID: 3918707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Australia antigen in Dahomey].
    Linhard J; Diebolt G; Darrasse D; de Medeiros D
    Bull Soc Med Afr Noire Lang Fr; 1973; 18(3):351-4. PubMed ID: 4206281
    [No Abstract]   [Full Text] [Related]  

  • 28. ABO and Rh(D) phenotype frequencies of different racial/ethnic groups in the United States.
    Garratty G; Glynn SA; McEntire R;
    Transfusion; 2004 May; 44(5):703-6. PubMed ID: 15104651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the safety of Rh immunoglobulin by monitoring viral markers among Rh-negative female blood donors.
    Watanabe KK; Busch MP; Schreiber GB; Zuck TF
    Vox Sang; 2000; 78(1):1-6. PubMed ID: 10729804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of hepatitis associated antigen in donors].
    Golosova TV; Margolina AN; Burlev VA; Tovstyko OI; Evgen'eva IM
    Probl Gematol Pereliv Krovi; 1972 Nov; 17(11):9-11. PubMed ID: 4201723
    [No Abstract]   [Full Text] [Related]  

  • 31. Infection with HIV, syphilis and hepatitis B in Ethiopia: a survey in blood donors.
    Rahlenbeck SI; Yohannes G; Molla K; Reifen R; Assefa A
    Int J STD AIDS; 1997 Apr; 8(4):261-4. PubMed ID: 9147161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High- and low-risk blood donors in Jerusalem: a survey of the hepatitis B antigen (HBsAg).
    Sandler SG; Shlomo AS; Shraga S; Ever-Hadani P
    Isr J Med Sci; 1975 Apr; 11(4):345-51. PubMed ID: 1140952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood group distribution in an urban population of patient targeted blood donors.
    Mwangi J
    East Afr Med J; 1999 Nov; 76(11):615-8. PubMed ID: 10734520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [HBeAg-anti-HBe markers in HBsAg carriers among volunteer donors].
    Nikiforova TV; Kulikova MM
    Gematol Transfuziol; 1985 Nov; 30(11):61-3. PubMed ID: 4085772
    [No Abstract]   [Full Text] [Related]  

  • 35. Maternal ABO and rhesus blood group phenotypes and hepatitis B surface antigen carriage.
    Lao TT; Sahota DS; Chung MK; Cheung TK; Cheng YK; Leung TY
    J Viral Hepat; 2014 Nov; 21(11):818-23. PubMed ID: 24325347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America.
    Hwang SJ; Tong MJ; Lai PP; Ko ES; Co RL; Chien D; Kuo G
    J Gastroenterol Hepatol; 1996 Oct; 11(10):949-54. PubMed ID: 8912133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Geographic risk factors for viral hepatitis and cytomegalovirus infection among United States Armed Forces blood donors.
    Hyams KC; Cross ER; Bianco MA; Soyk-Sarty DR; Roper CM; Dahut WL; Holmberg JA
    Transfusion; 1992 Sep; 32(7):644-7. PubMed ID: 1325694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occult hepatitis B virus infections and risk factors among school-going adolescent voluntary blood donors in Kwale County Kenya, January 2020-June 2021: Cross sectional study.
    Wahome PK; Kiende P; Nakazea RJ; Mwasowa NM; Nyamu GW
    PLoS One; 2022; 17(7):e0263473. PubMed ID: 35877674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study.
    Korelitz JJ; Busch MP; Kleinman SH; Williams AE; Gilcher RO; Ownby HE; Schreiber GB
    Transfusion; 1997 Jun; 37(6):634-40. PubMed ID: 9191825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea].
    Boumbaly S; Balde TAL; Semenov AV; Ostankova YV; Serikova EN; Naidenova EV; Valutite DE; Shchemelev AN; Zueva EB; Esaulenko EV; Totolian AA
    Vopr Virusol; 2022 Mar; 67(1):59-68. PubMed ID: 35293189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.